219 related articles for article (PubMed ID: 32894005)
1. Interleukin-5-producing malignant pleural mesothelioma with eosinophilic pleural effusion.
Takeuchi E; Takahashi N; Morizumi S; Tamiya H; Matsuoka H; Kuroda N; Yorita K
Thorac Cancer; 2020 Oct; 11(10):3043-3046. PubMed ID: 32894005
[TBL] [Abstract][Full Text] [Related]
2. Intrapleural Hyaluronidase in Viscous Malignant Mesothelioma Pleural Effusion.
Foo CT; Paterson A; Duckworth A; Herre J
Chest; 2021 Dec; 160(6):e609-e611. PubMed ID: 34872672
[TBL] [Abstract][Full Text] [Related]
3. Adenosine Deaminase in Pleural Effusion and Its Relationship with Clinical Parameters in Patients with Malignant Pleural Mesothelioma.
Nakajima Y; Kuribayashi K; Ishigaki H; Tada A; Negi Y; Minami T; Takahashi R; Doi H; Kitajima K; Yokoi T; Kijima T
Cancer Invest; 2020 Jul; 38(6):356-364. PubMed ID: 32468861
[TBL] [Abstract][Full Text] [Related]
4. Antitumor impact of interferon-γ producing CD1d-restricted NKT cells in murine malignant mesothelioma.
Tagawa T; Wu L; Anraku M; Yun Z; Rey-McIntyre K; de Perrot M
J Immunother; 2013 Oct; 36(8):391-9. PubMed ID: 23994885
[TBL] [Abstract][Full Text] [Related]
5. A case of malignant pleural mesothelioma with metastasis to the orbit.
Kubota K; Furuse K; Kawahara M; Ogawara M; Ryu S; Yamamoto S
Jpn J Clin Oncol; 1996 Dec; 26(6):469-71. PubMed ID: 9001354
[TBL] [Abstract][Full Text] [Related]
6. Malignant cells from pleural fluids in malignant mesothelioma patients reveal novel mutations.
Sneddon S; Dick I; Lee YCG; Musk AWB; Patch AM; Pearson JV; Waddell N; Allcock RJN; Holt RA; Robinson BWS; Creaney J
Lung Cancer; 2018 May; 119():64-70. PubMed ID: 29656754
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Nivolumab on Sarcomatoid Malignant Pleural Mesothelioma With Eosinophilia and Eosinophilic Pleural Effusion.
Yamazoe M; Ozasa H; Kim YH
J Thorac Oncol; 2019 Nov; 14(11):e251-e253. PubMed ID: 31668324
[No Abstract] [Full Text] [Related]
8. Small orangiophilic squamous-like cells: an underrecognized and useful morphological feature for the diagnosis of malignant mesothelioma in pleural effusion cytology.
Chen L; Caldero SG; Gmitro S; Smith ML; De Petris G; Zarka MA
Cancer Cytopathol; 2014 Jan; 122(1):70-5. PubMed ID: 23983174
[TBL] [Abstract][Full Text] [Related]
9. [An autopsy case of desmoplastic malignant mesothelioma].
Nakagomi T; Kitada O; Nakamura H; Miyata S; Aragane K; Kodama T; Kuribayashi K; Jin S; Takenaka N; Nagasawa N; Sugita M
Nihon Kokyuki Gakkai Zasshi; 2002 Aug; 40(8):697-702. PubMed ID: 12428402
[TBL] [Abstract][Full Text] [Related]
10. Young investigator challenge: MicroRNA-21/MicroRNA-126 profiling as a novel tool for the diagnosis of malignant mesothelioma in pleural effusion cytology.
Cappellesso R; Nicolè L; Caroccia B; Guzzardo V; Ventura L; Fassan M; Fassina A
Cancer Cytopathol; 2016 Jan; 124(1):28-37. PubMed ID: 26765063
[TBL] [Abstract][Full Text] [Related]
11. Intrapleural injection of brucea javanica oil emulsion provided a long-term benefits in patient with malignant pleural effusion from pleural mesothelioma: A case report.
Zhou H; Wang Q; Jiao L; Bi L; Sang S; Han Y; Gan S; Liu R; A G; Gong Y
Explore (NY); 2024; 20(1):126-129. PubMed ID: 37286465
[TBL] [Abstract][Full Text] [Related]
12. Palliative and therapeutic activity of IL-2 immunotherapy in unresectable malignant pleural mesothelioma with pleural effusion: Results of a phase II study on 31 consecutive patients.
Castagneto B; Zai S; Mutti L; Lazzaro A; Ridolfi R; Piccolini E; Ardizzoni A; Fumagalli L; Valsuani G; Botta M
Lung Cancer; 2001; 31(2-3):303-10. PubMed ID: 11165411
[TBL] [Abstract][Full Text] [Related]
13. G-CSF-producing malignant pleural mesothelioma: an autopsy case report with literature review.
Oka K; Sarashina G; Yonekawa N; Watanabe O; Miyao Y; Hashimoto T; Yatabe Y
Int J Surg Pathol; 2012 Jun; 20(3):272-5. PubMed ID: 21911431
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of methylthioadenosine phosphorylase and BRCA-associated protein 1 immunohistochemistry in the diagnosis of malignant mesothelioma in effusion cytology specimens.
Berg KB; Churg AM; Cheung S; Dacic S
Cancer Cytopathol; 2020 Feb; 128(2):126-132. PubMed ID: 31821740
[TBL] [Abstract][Full Text] [Related]
15. Clinically occult primary fallopian tube carcinoma presenting as a malignant pleural effusion.
Hiensch R; Meinhof K; Leytin A; Hagopian G; Szemraj E; Epelbaum O
Clin Respir J; 2017 Nov; 11(6):1086-1090. PubMed ID: 26646473
[TBL] [Abstract][Full Text] [Related]
16. Eosinophil colony-stimulating factor induced by administration of interleukin-2 into the pleural cavity of patients with malignant pleurisy.
Nakamura Y; Ozaki T; Yanagawa H; Yasuoka S; Ogura T
Am J Respir Cell Mol Biol; 1990 Oct; 3(4):291-300. PubMed ID: 2206537
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of pemetrexed and bevacizumab intrapleural injection for malignant pleural mesothelioma-mediated malignant pleural effusion.
Chen D; Li X; Zhao H; Fu Y; Yao F; Hu J; Du N
Indian J Cancer; 2014 Mar; 51 Suppl 3():e82-5. PubMed ID: 25818740
[TBL] [Abstract][Full Text] [Related]
18. Selection of microRNAs in extracellular vesicles for diagnosis of malignant pleural mesothelioma by in vitro analysis.
Jotatsu T; Izumi H; Morimoto Y; Yatera K
Oncol Rep; 2020 Nov; 44(5):2198-2210. PubMed ID: 33000251
[TBL] [Abstract][Full Text] [Related]
19. Factors that stimulate the proliferation and survival of eosinophils in eosinophilic pleural effusion: relationship to granulocyte/macrophage colony-stimulating factor, interleukin-5, and interleukin-3.
Nakamura Y; Ozaki T; Kamei T; Kawaji K; Banno K; Miki S; Fujisawa K; Yasuoka S; Ogura T
Am J Respir Cell Mol Biol; 1993 Jun; 8(6):605-11. PubMed ID: 8323745
[TBL] [Abstract][Full Text] [Related]
20. Local adoptive immunotherapy using lymphokine-activated killer cells and interleukin-2 against malignant pleural mesothelioma: report of two cases.
Yanagawa H; Sone S; Fukuta K; Nishioka Y; Ogura T
Jpn J Clin Oncol; 1991 Oct; 21(5):377-83. PubMed ID: 1753419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
